Brand Details Country of Origin United States 5501 Headquarters, Drive Suite 150W, Plano, TX 75024 Iron Asylum #17,2nd Main, Akshayanagar East, Yelenahalli, Bangalore, Karnataka 560068 India Email: [email protected], Phone: 9606990551 FSSAI licence Number: 11222999000706 Reviews There are no reviews yet
Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis
Financial support Support was provided solely from institutional and/or departmental sources
Animal studies showed retatrutide producing lower expression levels of inflammatory and fibrotic mediators compared to tirzepatide, suggesting the triple mechanism may offer benefits beyond additional weight loss
Candida-induced intestinal hyperpermeability requires dedicated repair